Ikarian Capital, LLC’s Sarepta Therapeutics Inc Position
Does Ikarian Capital, LLC own Sarepta Therapeutics Inc (SRPT)? Not currently — the last reported position was 449.1K shares worth $8M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$8M
Q2 2025
Shares
449.1K
% of Portfolio
+1.48%
Quarters Held
13
position exited
Position History SRPT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 449.1K | $8M | +1.48% |
| Q1 2025 | 169.1K | $11M | +1.33% |
| Q4 2024 | 34.1K | $4M | +0.56% |
| Q3 2024 | 54.2K | $7M | +0.94% |
| Q2 2024 | 203.6K | $32M | +5.60% |
| Q1 2024 | 152.3K | $20M | +2.16% |
| Q4 2023 | 132.6K | $13M | +1.20% |
| Q1 2023 | 8.3K | $1M | +0.26% |
| Q4 2022 | 28.3K | $4M | +0.89% |
| Q3 2022 | 16.8K | $2M | +0.37% |
| Q2 2022 | 25.0K | $2M | +0.34% |
| Q3 2021 | 6.5K | $602,000 | +0.04% |
| Q1 2021 | 134 | $10,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ikarian Capital, LLC’s full portfolio or all institutional holders of SRPT.